Europe: New Hemophilia A Medication Granted Orphan Status
An article from Clinical Leader today announced that the pharmaceutical company, Apitope, was recently granted orphan drug status for its…
Posts by tag: Pharmaceuticals
Pharma/Biotech Update: Bayer to File Application for Hemophilia Drug Extension
In an article released today by Yahoo News, Bayer Healthcare announced it will file for approval of its hemophilia drug Bay…
New Blog Dedicated to Life with ITP!
WeBleed.org/Sangramos.com is pleased to feature a blogger who is new to the bleeding, clotting and platelet disorders community. Candace, who…
Novo Nordisk set to announce hemophilia pipeline at ASH
Pharmaceutical company Novo Nordisk is set to release data on upcoming hemophilia and bleeding disorders medications at the 56th Annual Meeting…
Pharma/Biotech Update: Baxter Submits Application to FDA
According to an article today by Ellen Jean Hurst of the Chicago Tribune, Baxter International submitted an application to the…
Pharma/Biotech Update: New Hemophilia A Drug Gets Approval in Canada
According to a release today from the Pharmaceutical Business Review (PBR), a new hemophilia A (factor VIII deficiency) medication looks…
FDA Approves Acquired Hemophilia Drug
Yesterday the Food and Drug Administration (FDA) approved medication for a rare factor deficiency called acquired hemophilia A. The pharmaceutical,…
Baxalta (Baxter) Opening New Facility in Massachusetts
Industry news out of Chicago today in the field of bleeding disorders. According to an article by Kristen Schorsch of…
Novo Nordisk Introduces HERO Program
Hot off the presses. According to a release from MarketWatch, Novo Nordisk announced the launch of the HeroPath™ Life Coach…
Pfizer Gets Phase III Results, Acquires InnoPharma
Last week Pfizer announced that their hemophilia B factor medication, BeneFix, reduced the annual bleeding rate during once weekly prophylaxis…